Chemed Corp (CHE)

Return on total capital

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 353,475 321,541 305,574 321,467 334,263 346,914 365,175 353,651 352,182 401,721 387,701 412,491 398,345 332,882 318,863 284,130 266,144 249,399 245,448 239,086
Long-term debt US$ in thousands 16,250 92,500 95,850 111,800 120,000 185,000 160,000 90,000 130,000 85,000 100,000
Total stockholders’ equity US$ in thousands 1,107,880 1,019,240 952,079 880,053 798,715 721,416 684,960 666,705 623,273 779,719 870,774 928,884 901,200 801,408 750,696 683,601 726,608 672,380 618,569 588,010
Return on total capital 31.91% 31.55% 32.10% 35.87% 37.51% 42.45% 45.83% 44.95% 43.57% 51.52% 44.52% 44.41% 44.20% 41.54% 42.48% 33.68% 32.59% 31.08% 34.89% 34.75%

December 31, 2023 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $353,475K ÷ ($—K + $1,107,880K)
= 31.91%

The return on total capital for Chemed Corp. has been fluctuating over the past eight quarters, ranging from a low of 30.94% in Q4 2023 to a high of 46.39% in Q3 2022. The trend shows a general decrease in return on total capital over the quarters from 46.39% in Q3 2022 to 30.94% in Q4 2023.

This decline may raise concerns about the company's ability to generate returns on the total funds invested in its operations. However, it is important to consider the industry norms and compare Chemed Corp.'s return on total capital with its peers to gain a better perspective on its performance. Further analysis should involve examining the factors contributing to the downward trend and identifying opportunities for improvement to enhance the company's overall financial health.


Peer comparison

Dec 31, 2023